Department of Cardiovascular Medicine, Graduate School of Medicine, University of Tokyo, Japan.
FEBS Lett. 2013 Jul 11;587(14):2179-85. doi: 10.1016/j.febslet.2013.05.038. Epub 2013 May 24.
Vascular endothelial growth factor-A (VEGF-A) is one of the major angiogenic factors, and its actions are primarily mediated through its two membrane receptors, VEGFR-1 and VEGFR-2. A soluble form of VEGFR-1 (sVEGFR-1) sequesters the free form of VEGF-A, and acts as a potent anti-angiogenic factor. While sVEGFR-1 is synthesized as a splice variant of VEGF-R1 gene, the interactions between VEGF-A and sVEGFR-1 remain largely unknown. Here, we show that VEGF-A upregulates sVEGF-R1 expression in human vascular endothelial cells but leaves full-length VEGF-R1 expression unchanged, and that this induction was dependent on the VEGFR-2-protein kinase C-MEK signaling pathway. The VEGF-A-induced sVEGFR-1 upregulation can operate as a negative feedback system, which if modulated can become a novel therapeutic target for regulating pathological angiogenesis.
血管内皮生长因子-A(VEGF-A)是主要的血管生成因子之一,其作用主要通过其两个膜受体,VEGFR-1 和 VEGFR-2 来介导。VEGFR-1 的可溶性形式(sVEGFR-1)可隔离游离形式的 VEGF-A,并起到有效的抗血管生成作用。虽然 sVEGFR-1 作为 VEGF-R1 基因的剪接变体而合成,但 VEGF-A 与 sVEGFR-1 之间的相互作用在很大程度上仍不清楚。在这里,我们发现 VEGF-A 可上调人血管内皮细胞中 sVEGFR-1 的表达,但不改变全长 VEGFR-1 的表达,并且这种诱导依赖于 VEGFR-2-蛋白激酶 C-MEK 信号通路。VEGF-A 诱导的 sVEGFR-1 上调可作为负反馈系统发挥作用,如果对其进行调节,可能成为调节病理性血管生成的新的治疗靶标。